The 2 analysts offering 12-month price forecasts for IRadimed Corp have a median target of 28.00, with a high estimate of 30.00 and a low estimate of 26.00. The median estimate represents a +23.08% increase from the last price of 22.75.
The current consensus among 2 polled investment analysts is to Buy stock in IRadimed Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.11
Reporting Date Feb 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.